If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
21.50    0.00 (0.00%)
Bid:
21.00
Ask:
22.00
Spread: 1.00 (4.762%)
Market Cap: £23.22m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Disposal update

7 Jun 2013 07:00

RNS Number : 5345G
Elektron Technology PLC
07 June 2013
 



7 June 2013

 

Elektron Technology plc

 

Conditional disposal of Total Carbide Limited - update

 

Elektron Technology plc (AIM: EKT, "Elektron" or the "Group"), the global technology group), has exchanged contracts on the sale of its subsidiary, Total Carbide Limited ("Total Carbide"), to Versarien plc ("Versarien"), for a total consideration of approximately £2.3 million of which approximately £1.23 million (net) is in cash and £1.05 million is in shares in Versarien ("the Consideration Shares"). The consideration represents the approximate net asset value of Total Carbide.

 

Total Carbide, a wholly owned subsidiary of Elektron, is a leading European manufacturer of sintered tungsten carbide components for a number of key industries and supplies several major European companies. The disposal of Total Carbide remains conditional upon the admission of Versarien to trading on AIM ("Admission") which is expected in due course. On completion of the disposal, Elektron will hold approximately 10.3% of Versarien's share capital following Admission.

 

Approximately £0.7 million of Consideration Shares are required to be held by Elektron for a minimum period of 6 months and will be held as an investment. There are no restrictions on the balance of £0.35 million Consideration Shares. The cash proceeds of the disposal will be used by Elektron to reduce borrowings.

 

The proposed disposal is part of the Group's rationalisation of its portfolio, focusing its investment in its core brands and key segments of Connectivity and IMC (Instrumentation, Monitoring and Control). Elektron is continuing to transform its business, building an innovation-led technology company through its strategy of innovation, streamlining operations, investing in infrastructure, people and capabilities, as well as focusing resources on key brands and product offerings.

 

Further details on Versarien and its Admission to AIM can be found at

www.londonstockexchange.com/exchange/prices-and-markets/stocks/new-and-recent-issues/new-recent-issue-details.html?issueId=8837

 

 

Enquiries:

 

Elektron Technology www.elektron-technology.com

+44 (0)1223 371 000

Keith Daley - Chairman

Noah Franklin - Chief Financial Officer

finnCap

+44 (0)20 7220 0500

Ed Frisby/ Rose Herbert - Corporate Finance

Simon Starr/Victoria Bates - Corporate Broking

College Hill

+44 (0)20 7457 2020

Adrian Duffield/Rozi Morris

 

 

Notes to Editors

 

Elektron Technology is a global designer and manufacturer of precision engineered products which enable two of the most important technology areas of the always-on, networked economy: Connectivity and Instrumentation, Monitoring and Control ('IMC').

 

The Group has a broad portfolio of brands which are recognised leaders in their markets, playing a critical role in many industries from underwater construction to food preparation, semiconductor manufacture to emergency vehicle systems. The Group's products are sold worldwide to over 7,000 customers, around 100,000 end-users, and used in all seven continents and in space.

 

Elektron Technology is headquartered in Cambridge and traded on the AIM market of the London Stock Exchange.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISLIFSERLIDIIV
Date   Source Headline
19th Jan 20177:00 amRNSDirector/PDMR Shareholding
14th Dec 20164:54 pmRNSHolding(s) in Company
13th Dec 20167:00 amRNSDirector/PDMR Shareholding
8th Dec 20169:00 amRNSReview of Operations
2nd Dec 20167:00 amRNSDisposal
30th Sep 20162:43 pmRNSDisposal of Carnation Designs
22nd Sep 20167:00 amRNSHalf-year Report
30th Aug 20169:52 amRNSHolding(s) in Company
1st Aug 20167:00 amRNSDirector/PDMR Shareholding
28th Jul 20163:56 pmRNSResult of AGM
28th Jul 20167:00 amRNSTrading Update
4th Jul 201610:40 amRNSLapsing of Options
30th Jun 20167:00 amRNSAnnual Report and Notice of AGM
9th Jun 20167:00 amRNSFinal Results
23rd May 20167:00 amRNSDisposal of Agar Scientific
18th May 20169:56 amRNSHolding(s) in Company
13th May 201610:06 amRNSHolding(s) in Company
20th Apr 20162:54 pmRNSDerivative Claim - Update
22nd Feb 20167:00 amRNSTrading Update
26th Jan 20167:00 amRNSDirectorate Change
20th Jan 20163:22 pmRNSHolding(s) in Company
25th Nov 20157:00 amRNSProduct Launch
24th Nov 20153:21 pmRNSHolding(s) in Company
10th Nov 20157:00 amRNSTrading Update
19th Oct 20153:41 pmRNSDerivative Claim - Update
5th Oct 20157:00 amRNSProduct Launch
28th Sep 20157:00 amRNSDirector's Dealing
14th Sep 20154:12 pmRNSDirector's dealing
10th Sep 20157:00 amRNSDirectorate Changes
10th Sep 20157:00 amRNSHalf Yearly Report
30th Jul 20154:45 pmRNSResult of AGM
23rd Jul 20159:00 amRNSTrading Update
22nd Jul 20157:00 amRNSDerivative claim - update
16th Jul 20154:09 pmRNSDerivative Claim - Update
8th Jul 20153:16 pmRNSLapse of Options
6th Jul 20153:49 pmRNSNotice of AGM
26th Jun 20154:00 pmRNSHolding(s) in Company
18th Jun 20158:50 amRNSDerivative Claim - Update
12th Jun 20154:42 pmRNSAnnual Report and Financial Statements
30th Apr 20157:00 amRNSFinal Results
27th Apr 20155:35 pmRNSHolding(s) in Company
7th Apr 20151:41 pmRNSHolding(s) in Company
12th Feb 20157:00 amRNSYear end trading update
28th Jan 201512:45 pmRNSDerivative Claim - Further Update
24th Nov 20147:00 amRNSTrading update
2nd Oct 20147:00 amRNSDerivative Claim - Update
31st Jul 20146:06 pmRNSResult of AGM
31st Jul 20147:00 amRNSAGM Statement
25th Jul 201411:15 amRNSDirector/PDMR Shareholding
17th Jul 201412:15 pmRNSResult of Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.